NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO NEWS DISTRIBUTORS IN THE UNITED STATES, OR FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR PUBLICATION WOULD NOT BE ALLOWED BY APPLICABLE LAW.
Aino Health AB will be listed on Nasdaq First North with first day of trade on December 16th
Aino Health AB (publ) (“Aino Health” or the “Company”) has applied and been approved for trade on Nasdaq First North. The first day of trade is the 16th of December 2016.
The trade name for Aino Health is AINO with the ISIN-code SE0009242555. The company’s prospectus for the share issue and information about the company can be found on the company’s web site www.ainohealth.com.
Erik Penser AB is the Certified Advisor.
Publication and distribution of this press release may in certain jurisdictions be restricted by law and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and follow such restrictions. The information in this press release is not an offer to acquire, subscribe for or otherwise trade in shares or another security in Aino Health.
This press release may not be released, published or distributed, directly or indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Singapore, South Africa or another country where such action requires further measures in addition to what follows from Swedish law or where this would contravene with laws or regulations of that country. The information in this press release may not be forwarded, reproduced or disclosed in ways that conflict with such restrictions. Omission to follow this instruction may constitute a violation of the United States Securities Act of 1933 (the “Securities Act”) in its present terms or applicable laws in other jurisdictions.
This information is such information that Aino Health AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at December 15, 2016 at 8:30 CET.
For more information, please contact:
Jyrki Eklund, CEO
Phone: +358 40 042 4221
Cecilia Hollerup, Chairman of the Board of Directors
Phone: +46 70 829 33 36
About Aino Health
Aino Health operates within Corporate Health Management. The company has developed a complete system of IT-based services with a focus to improve corporate health and reduce sickness absence levels in private and public organizations.